Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage. 2003

Preston R Miller, and J Wayne Meredith, and Michael C Chang
Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. pmiller@wfubmc.edu

BACKGROUND Identification of ventilator-associated pneumonia (VAP) with invasive methods such as bronchoalveolar lavage (BAL) paired with treatment is associated with improved mortality. Inappropriate antibiotic use, however, is known to increase bacterial resistance, making future treatment problematic. Thus, the diagnostic threshold for VAP in BAL must yield adequate sensitivity while limiting exposure of patients to unnecessary antibiotics. Our institution uses a cutoff of > or = 10(5) colony-forming units (CFUs)/mL, but the optimal cutoff remains an area of debate. In this project, the effects of lower diagnostic cutoffs on VAP diagnosis and unnecessary antibiotic use are examined. METHODS Records of all patients admitted to the trauma intensive care unit over a 2-year period requiring > 48 hours of mechanical ventilation were reviewed. Number of BALs, quantity of organism on each BAL, and presence of VAP (> or = 10(5) CFUs/mL) were noted. Indication for BAL was pulmonary infiltrate, sepsis syndrome, and C-reactive protein > 17 microg/dL at > or = 48 hours after admission. RESULTS From January 1, 2000, to December 31, 2001, 563 patients were admitted to the trauma intensive care unit. Two hundred fifty-seven required > 48 hours of mechanical ventilation, and 257 BALs were performed in 168 (65%) of these patients. One hundred thirty-nine episodes of VAP occurred in 109 (42%) patients. Subdiagnostic quantities of bacteria (> or = 10(2) but < 10(5) CFUs/mL) were seen in 98 BALs. Of these, only 16 (16%) episodes of VAP with the same organism were seen later during hospitalization. At a threshold of > or = 10(4) CFUs/mL, 4 of 28 (14%) patients went on to develop pneumonia. A similar pattern was seen at diagnostic thresholds of > or = 10(3) CFUs/mL (10 of 72 [14%]) and > or = 10(2) CFUs/mL (16 of 98 [16%]). CONCLUSIONS A threshold of > or = 10(5) CFUs/mL for VAP diagnosis carries a low false-negative rate. Over 80% of additional patients who would have been treated had a threshold of > or = 10(4) CFUs/mL been used recovered without treatment and thus would have undergone unnecessary antibiotic exposure. A similar pattern is seen at all lower thresholds. Lower diagnostic thresholds would lead to marginal increase in sensitivity, and many would receive unnecessary VAP treatment with potential for increasing bacterial resistance.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012122 Ventilators, Mechanical Mechanical devices used to produce or assist pulmonary ventilation. Mechanical Ventilator,Mechanical Ventilators,Respirators,Ventilators, Pulmonary,Pulmonary Ventilator,Pulmonary Ventilators,Ventilator, Pulmonary,Ventilators,Respirator,Ventilator,Ventilator, Mechanical
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Preston R Miller, and J Wayne Meredith, and Michael C Chang
October 2007, Anaesthesia,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
September 2009, Journal of clinical microbiology,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
July 1996, The European respiratory journal,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
December 2012, Surgical infections,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
January 2005, The Journal of burn care & rehabilitation,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
January 2006, The Turkish journal of pediatrics,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
February 2013, The journal of trauma and acute care surgery,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
December 2007, The Journal of trauma,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
December 1999, British journal of anaesthesia,
Preston R Miller, and J Wayne Meredith, and Michael C Chang
August 1994, Critical care medicine,
Copied contents to your clipboard!